AbCellera Biologics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ABCL for the last quarter is 6.51 M USD, and it's 11.14% lower compared to the previous quarter. The net income of Q3 24 is -51.11 M USD.